New Zealand markets close in 5 hours 21 minutes

Pfizer Inc. (PFE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
53.99+0.28 (+0.52%)
At close: 04:03PM EDT
54.00 +0.01 (+0.02%)
After hours: 07:36PM EDT
Full screen
Loading interactive chart…
  • Business Wire

    Pfizer Granted FDA Fast Track Designation for Ervogastat/Clesacostat Combination for the Treatment of Non-Alcoholic Steatohepatitis (NASH)

    NEW YORK, May 26, 2022--Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Pfizer’s investigational combination therapy for the treatment of non-alcoholic steatohepatitis (NASH) with liver fibrosis: ervogastat (PF-06865571, a diacylglycerol O-acyltransferase 2 inhibitor, or DGAT2i) and clesacostat (PF-05221304, an acetyl-CoA carboxylase inhibitor, or ACCi). Fast Track is a process designed to facilitate the development and ex

  • Motley Fool

    Better Dividend Stock: Pfizer or Merck?

    Pfizer (NYSE: PFE) and Merck (NYSE: MRK) have been giants in the pharmaceutical industry for years. The first metric that most investors look at when comparing dividend stocks is the dividend yield. Pfizer gets the nod with a dividend yield of 3.05%, a little higher than Merck's yield of 2.95%.

  • Motley Fool

    How Vaccine Cash Could Fuel Pfizer's Future Growth

    Thanks to the success of its COVID-19 vaccine, Pfizer (NYSE: PFE) more than doubled its cash hoard in 2021. Here's how the company's big plan might play out. Pfizer set forth an ambitious goal to use its war chest to add $25 billion of revenue by 2030  through mergers and acquisitions, and it's been actively building its pipeline to reach that goal over the last several months.